Concepedia

Christopher G. Hallgren

CG

Statistics

Publications

2

Citations

337

H-Index

2

Active since

2001

Affiliations

Mayo Clinic in Arizona(Current)

Christopher G. Hallgren is an author at Mayo Clinic in Arizona specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2001–2002

2

Publications

2

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren et al. · PubMed · 2001 · 223 citations

, , +17

Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro

Benjamin Mow, Joya Chandra, Phyllis A. Svingen et al. · Blood · 2002 · 114 citations · Full text

, , +9

1–2 of 2